- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 11/14 - Antitussive agents
Patent holdings for IPC class A61P 11/14
Total number of patents in this class: 398
10-year publication summary
|
14
|
18
|
39
|
22
|
38
|
43
|
45
|
30
|
30
|
15
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Boehringer Ingelheim International GmbH | 4705 |
10 |
| Glaxosmithkline Intellectual Property (no.2) Limited | 282 |
10 |
| Chiesi Farmaceutici S.p.A. | 950 |
10 |
| Wuhan LL Science and Technology Development Co., Ltd | 72 |
9 |
| Institute of Materia Medica, Chinese Academy of Medical Sciences | 177 |
8 |
| The Procter & Gamble Company | 22034 |
7 |
| Biocopea Limited | 21 |
7 |
| Genexa Inc. | 40 |
7 |
| Nippon Chemiphar Co., Ltd. | 229 |
6 |
| Daiichi Sankyo Company, Limited | 1848 |
5 |
| Shionogi & Co., Ltd. | 873 |
5 |
| Verona Pharma plc | 101 |
5 |
| The First Affiliated Hospital of Guangzhou Medical University | 16 |
5 |
| Guangzhou Institute of Respiratory Disease | 10 |
5 |
| Chengdu Shibeikang Biomedical Technology Co., Ltd. | 19 |
5 |
| Jiangsu Kanion Pharmaceutical Co., Ltd. | 81 |
4 |
| Salus Pharma Technology (Shanghai) Co., Ltd. | 4 |
4 |
| AstraZeneca AB | 2933 |
3 |
| Bayer AG | 3286 |
3 |
| Toray Industries, Inc. | 6865 |
3 |
| Other owners | 277 |